Company news
Suzhou Fengbei Biotech Stock Co., Ltd. Class A (SSE:603334) news
Suzhou Fengbei Biotech Stock Co., Ltd. Class A news releases on 6ix. Latest, Sep 22, 2026: "SUZHOU FENGBEI BIOTECH STOCK CO., LTD."Announcement on Convening…
Press releases & updates
"SUZHOU FENGBEI BIOTECH STOCK CO., LTD."Announcement on Convening the 2026 Semi-annual Performance Briefing
September 21, 2026
"SUZHOU FENGBEI BIOTECH STOCK CO., LTD."Announcement on Progress in Providing Guarantee for Controlled Subsidiary
September 16, 2026
"SUZHOU FENGBEI BIOTECH STOCK CO., LTD."Semi-annual Report for 2026
August 23, 2026
"SUZHOU FENGBEI BIOTECH STOCK CO., LTD."Announcement on Redemption at Maturity of Certain Idle Raised Funds Used for Cash Management
July 30, 2026
"SUZHOU FENGBEI BIOTECH STOCK CO., LTD."Announcement on Progress of Providing Guarantees for Wholly-owned Subsidiaries
July 24, 2026
"SUZHOU FENGBEI BIOTECH STOCK CO., LTD."Announcement on Redemption at Maturity of Partial Idle Raised Funds Used for Cash Management
July 1, 2026
Announcement on Progress of Providing Guarantees for Wholly-owned Subsidiaries
June 16, 2026
Announcement on Implementation of Dividend Distribution for 2025
June 1, 2026
Announcement on Convening Performance Briefing for 2025 and Q1 2026
May 12, 2026
Announcement on Resolutions of the 2025 Annual General Meeting
May 7, 2026
Report for Q1 2026
April 28, 2026
Announcement on Circulation of Partial Restricted Shares in Offline Placement of Initial Public Offering
April 27, 2026
Announcement on Opening Special Settlement Account for Cash Management of Raised Funds
April 23, 2026
Notice on Convening the 2025 Annual General Meeting
April 9, 2026
Announcement on Redemption at Maturity of Partial Idle Raised Funds Used for Cash Management
April 1, 2026
Announcement on Abnormal Fluctuations in Stock Trading
February 5, 2026
Announcement on Completing Industrial and Commercial Change Registration and Obtaining Renewed Business License
December 26, 2025
Announcement on Conducting Forward Foreign Exchange Settlement and Sale and Other Foreign Exchange Derivatives Transactions
December 9, 2025